Browse > Article
http://dx.doi.org/10.4333/KPS.2010.40.6.353

Preparation and Characterization of Bovine Serum Albumin-loaded Cationic Liposomes: Effect of Hydration Phase  

Park, Se-Jin (College of Pharmacy, Chungnam National University)
Jeong, Ui-Hyeon (College of Pharmacy, Chungnam National University)
Lee, Ji-Woo (College of Pharmacy, Chungnam National University)
Park, Jeong-Sook (College of Pharmacy, Chungnam National University)
Publication Information
Journal of Pharmaceutical Investigation / v.40, no.6, 2010 , pp. 353-356 More about this Journal
Abstract
Although liposomes have been applied as drug delivery systems in various fields, the usage was limited due to the low encapsulation efficiency compared to other carrier systems. Here, cationic liposomes were prepared by mixing 1,2-dioleoyl-3-trimethylammoniopropane (DOTAP) as a cationic lipid, 1,2-dioleoyl-sn-glycerol-phosphoethanolamine (DOPE) and cholesterol (CH), and the liposomes were hydrated by varying the aqueous phases such as phosphate-buffered saline (PBS), 5% dextrose, and 10% sucrose in order to improve the encapsulation efficiency of bovine serum albumin (BSA). The particle size and zeta potential were determined by dynamic light scattering method and in vitro release patterns were investigated by spectrophotometry. Particle size and zeta potential of liposomes were varied depending on the ratio of DOTAP/DOPE/CH in range of 270-350 nm and 0.8-9.7 mV, respectively. Moreover, the addition of polyethylene glycol (PEG) improved the encapsulation efficiency from 37% to 43% as well as reduced particle sizes of liposomes while the liposomes were hydrated in PBS. When the liposomes were hydrated with 10% sucrose, the encapsulation efficiency of BSA was higher than any other groups. Whereas PBS was used as hydration solution, lower encapsulation efficiency was obtained compared with other groups. More than 60% of BSA was released from the liposomes hydrated with 10% sucrose; thereafter another 20% of BSA was released. Therefore, release pattern of BSA from cationic liposomes was extended release in this study. From the results, cationic liposomes dispersed in 10% sucrose would be potential carrier with high encapsulation efficiency.
Keywords
Liposomes; Bovine serum albumin; Encapsulation; In vitro release;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Lee, K.Y., Yuk, S.H., 2007. Polymeric protein delivery systems. Prog. Polym. Sci. 32, 669-697.   DOI
2 Lian, T., Ho, R.J., 2001. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 90, 667-680.   DOI
3 Manosroi, A., Khanrin, P., Werner, R.G., Gotz, F., Manosroi, W., Manosroi, J., 2010. Entrapment enhancement of pepetide drugs in niosomes. J. Microencapsul. 27, 272-280.   DOI
4 Meyenburg, S., Lilie, H., Panzner, S., Rudolph, R., 2000. Fibrin encapsulated liposomes as protein delivery system: Studies on the in vitro release behavior. J. Control. Release 69, 159-168.   DOI
5 Mokhtar, M., Sammour, O.A., Hammad, M.A., Megrab, N.A., 2008. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int. J. Pharm. 361, 104-111.   DOI   ScienceOn
6 van Winden, E.C., 2003. Freeze-drying of liposomes: theory and practice. Meth. Enzymol. 367, 99-110.   DOI
7 Vandana, M., Sahoo, S.K., 2009. Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles. Nanomedicine (Lond) 4, 773-785.   DOI
8 Wang, W., 2005. Protein aggregation and its inhibition in biopharmaceutics. Int. J. Pharm. 289, 1-30.   DOI
9 Werle, M., Bernkop-Schnurch, A., 2006. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 30, 351-367.   DOI
10 Blume, G., Cevc, G., 1990. Liposomes for the sustained drug release in vivo. Biochim. Biophys. Acta 1029, 91-97.   DOI
11 Crowe, J.H., Tsvetkova, N.M., Oliver, A.E., Leidy, C., Ricker, J., Crowe, L.M., 2006. Stabilization of liposomes by freeze-drying: lessons from nature. In: Gregoriadis, G. (Ed.), Liposome Technology, Vol. I: Liposome Preparation and Related Techniques, 3rd Ed., Informa Healthcare, USA.
12 Debs, R.J., Fuchs, H.J., Philip, R., Brunette, E.N., Duzgunes, N., Shellito, J.E., Liggitt, D., Patton, J.R., 1990. Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats. Cancer Res. 50, 375-380.
13 Gabizon, A., Martin, F., 1997. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumors. Drugs 54, 15-21.
14 Jeong, U.H., Jung, J.H., Davaa, E., Park, S.J., Myung, C.S., Park, J.S., 2009. Effect of drug loading on the physicochemical properties and stability of cationic lipid-based plasmid DNA complexes. J. Kor. Pharm. Sci. 39, 339-343.   과학기술학회마을   DOI
15 Katayama, K., Kato, Y., Onishi, H., Nagai, T., Machida, Y., 2003. Double liposomes: hypoglycemic effects of liposomal insulin on normal rats. Drug Dev. Ind. Pharm. 29, 725-731.   DOI   ScienceOn
16 Kim, J.K., Choi, S.H., Kim, C.O., Park, J.S., Ahn, W.S., Kim, C.K., 2003. Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency. J. Pharm. Pharmacol. 55, 453-460.   DOI   ScienceOn
17 Kim, J.Y., Kim, J.K., Park, J.S., Byun, Y., Kim, C.K., 2009. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator. Biomaterials 30, 5751-5756.   DOI